SEC Form 4 · accession 0001415889-16-007054
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert N Fried
Director
Period of report
Sep 1, 2016
Accepted (ET)
Sep 6, 2016 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2016 | P | 15,000 | $3.39 | A | 66,979 | D | |
| Common StockF1 | holding | — | — | — | 12,744 | I | See Footnote 1 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F16,744 shares held by Jeremy Fried and 6,000 shares held by Benjamin Fried, who are both sons of Robert Fried.